ArticleBMC surgery2025
An easily acquirable predictive model for strangulated bowel obstruction: the BAR-N.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictive models for intestinal obstruction: from clinical scores to artificial intelligence.Frontiers in surgery · 2026Review
- Advancing precision triage in strangulated small bowel obstruction: from static scores to dynamic multiparametric models.Frontiers in surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSmall bowel obstruction (SBO) is a prevalent gastrointestinal disorder that consists primarily of two types: simple bowel obstruction (SiBO) and strangulated bowel obstruction (StBO). Due to life-threatening complications such as septic shock and multiple organ dysfunction syndrome, there is an urgent need for an easy-to-acquire predictive model for StBO based on clinical symptoms and laboratory.
methodsA total of 453 patients diagnosed with SBO were randomly divided into training and validation datasets at a ratio of 7:3. The demographic, clinical, and laboratory data were collected. Least absolute shrinkage and selection operator (LASSO) regression was employed to identify relevant variables, and a multivariable logistic regression (LR) model was subsequently developed. The performance of the model was evaluated using receiver operating characteristic (ROC) curve analysis, and diagnostic metrics, including accuracy, sensitivity, specificity, and area under the curve (AUC), were calculated.
resultsOf the 453 patients diagnosed with SBO, 62 (13.7%) had StBO, and 391 (86.3%) had SiBO. Univariate analysis revealed significant associations between bowel ischemia and the following variables: body mass index (BMI, p = 0.027), neutrophil percentage (N, p = 0.002), aspartate aminotransferase (AST, p = 0.024), serum creatinine (p = 0.030), serum urea (p = 0.019), glucose (p = 0.029), prothrombin time (PT, p = 0.043), cessation of defecation and flatus (p = 0.013), tenderness (p = 0.004), and rebound tenderness (p < 0.001). A LASSO regression model with optimized regularization parameters (α = 0.3, λ = 0.0202; log[λ] = - 3.902) was used to select 10 predictors. Rebound tenderness (OR, 6.64; 95% CI, 2.97-15.48; p < 0.001), BMI (OR, 0.02; 95% CI, 0.00-0.37; p = 0.010), N (OR, 1.05; 95% CI,1.01-1.09; p = 0.009), and AST (OR, 1.97; 95% CI, 1.01-4.06, p = 0.055) were significantly associated with intestinal ischemia via multivariable LR. The final predictive model (BAR-N) had a strong performance, with an AUC of 0.784 in the training cohort and 0.750 in the validation cohort. Additionally, the model exhibited high specificity (90.3%) and accuracy (80.7%), although its sensitivity remained relatively low at 31.8%.
conclusionsWe developed an easy-to-acquire predictive model (BAR-N) for the diagnosis of StBO that incorporates both clinical and laboratory data. This model shows promise as an adjunctive decision-support tool, particularly in resource-limited or high-acuity settings. However, its generalizability is limited by the absence of external validation, underscoring the need for future multicenter studies to confirm its broader applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.